Literature DB >> 8355188

Apparent mediation of the stimulus properties of a low dose of quinpirole by dopaminergic autoreceptors.

D V Widzowski1, D A Cory-Slechta.   

Abstract

This study examined the hypothesis that, if the stimulus properties of the D2 agonist quinpirole (QUIN) were mediated by autoreceptors, then pharmacological treatments engendering a decline in dopamine (DA) release and consequent decrease in postsynaptic DA receptor stimulation should result in QUIN-appropriate responding; those that activate postsynaptic receptors should result in saline-appropriate responding. In rats trained to discriminate 0.05 mg/kg of QUIN from saline using standard operant drug discrimination procedures, QUIN (up to the training dose), two other putative D2 autoreceptor agonists (low-dose apomorphine and N-propylnorapomorphine), the DA depeleter alpha-methyl-p-tyrosine (AMPT) and the D1 antagonist SCH 23390 all produced primarily QUIN-lever responding. Moreover, coadministration of alpha-methyl-p-tyrosine with QUIN potentiated QUIN-stimulus properties. Higher doses of apomorphine, known to stimulate postsynaptic D1 and D2 receptors and pretreatment with the D2 antagonist haloperidol decreased QUIN-lever responding. Neither the D1 agonist SKF38393, the indirect D1/D2 agonist d-amphetamine, the D2 antagonist haloperidol or coadministration of SCH 23390 and d-amphetamine substituted for QUIN. Coadministration of either SKF 38393 or d-amphetamine with QUIN decreased levels of QUIN responding. Taken together, the data are consistent with the contention that the stimulus properties of 0.05 mg/kg of QUIN are primarily mediated by D2-type presynaptic autoreceptors and that these stimulus properties involve a decline in DA release and consequent decreased postsynaptic stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355188

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging.

Authors:  Yin-Ching I Chen; Ji-Kyung Choi; Susan L Andersen; Bruce R Rosen; Bruce G Jenkins
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

2.  Dopamine D3 receptors mediate the discriminative stimulus effects of quinpirole in free-feeding rats.

Authors:  Michelle G Baladi; Amy H Newman; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2009-10-01       Impact factor: 4.030

3.  Altered dopamine D2 receptor function and binding in obese OLETF rat.

Authors:  Andras Hajnal; Wojciech M Margas; Mihai Covasa
Journal:  Brain Res Bull       Date:  2007-08-08       Impact factor: 4.077

4.  Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses.

Authors:  Jiaqian Ren; Haibo Xu; Ji-Kyung Choi; Bruce G Jenkins; Y Iris Chen
Journal:  Synapse       Date:  2009-09       Impact factor: 2.562

5.  Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.

Authors:  Tina Scardochio; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

6.  Involvement of dopamine D2 receptors in addictive-like behaviour for acetaldehyde.

Authors:  Anna Brancato; Fulvio Plescia; Rosa Anna Maria Marino; Giuseppe Maniaci; Michele Navarra; Carla Cannizzaro
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

7.  Enhanced Dopamine in Prodromal Schizophrenia (EDiPS): a new animal model of relevance to schizophrenia.

Authors:  Alice Petty; Xiaoying Cui; Yasvir Tesiram; Deniz Kirik; Oliver Howes; Darryl Eyles
Journal:  NPJ Schizophr       Date:  2019-03-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.